E95: Rituximab or Cyclophosphamide in ANCA Vasculitis

Fun study this week from JAMA Network Open and the French Vasculitis Study Group. They used a target trial emulation (one of my favorites) to ask whether RTX > CYC in AAV (another one of my favorites). I tried to use this to compare between observational and randomized data. 

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018